BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

33 related articles for article (PubMed ID: 12517939)

  • 1. Local delivery of interleukin 4 by retrovirus-transduced T lymphocytes ameliorates experimental autoimmune encephalomyelitis.
    Shaw MK; Lorens JB; Dhawan A; DalCanto R; Tse HY; Tran AB; Bonpane C; Eswaran SL; Brocke S; Sarvetnick N; Steinman L; Nolan GP; Fathman CG
    J Exp Med; 1997 May; 185(9):1711-4. PubMed ID: 9151908
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Experimental autoimmune encephalomyelitis induction in genetically B cell-deficient mice.
    Wolf SD; Dittel BN; Hardardottir F; Janeway CA
    J Exp Med; 1996 Dec; 184(6):2271-8. PubMed ID: 8976182
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Viewing Autoimmune Pathogenesis from the Perspective of Antigen Processing and Determinant Hierarchy.
    Moudgil KD
    Crit Rev Immunol; 2020; 40(4):329-339. PubMed ID: 33426821
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Global expression profiling of peripheral Qa-1-restricted CD8αα+TCRαβ+ regulatory T cells reveals innate-like features: implications for immune-regulatory repertoire.
    Fanchiang SS; Cojocaru R; Othman M; Khanna R; Brooks MJ; Smith T; Tang X; Maricic I; Swaroop A; Kumar V
    Hum Immunol; 2012 Mar; 73(3):214-22. PubMed ID: 21889557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Involvement of IFN-γ and perforin, but not Fas/FasL interactions in regulatory T cell-mediated suppression of experimental autoimmune encephalomyelitis.
    Beeston T; Smith TR; Maricic I; Tang X; Kumar V
    J Neuroimmunol; 2010 Dec; 229(1-2):91-7. PubMed ID: 20708278
    [TBL] [Abstract][Full Text] [Related]  

  • 6. T-lymphocytes mediate left ventricular fibrillar collagen cross-linking and diastolic dysfunction in mice.
    Yu Q; Vazquez R; Zabadi S; Watson RR; Larson DF
    Matrix Biol; 2010 Jul; 29(6):511-8. PubMed ID: 20600894
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD8alpha+ dendritic cells prime TCR-peptide-reactive regulatory CD4+FOXP3- T cells.
    Smith TR; Maricic I; Ria F; Schneider S; Kumar V
    Eur J Immunol; 2010 Jul; 40(7):1906-15. PubMed ID: 20394075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaccines for multiple sclerosis: progress to date.
    Correale J; Farez M; Gilmore W
    CNS Drugs; 2008; 22(3):175-98. PubMed ID: 18278975
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TAP1-/- mice present oligoclonal BV-BJ expansions following the rejection of grafts bearing self antigens.
    Marrero I; Huffman D; Kalil J; Sercarz EE; Coelho V
    Immunology; 2006 Aug; 118(4):461-71. PubMed ID: 16895555
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of intradermal vaccination with DNA encoding for the T-cell receptor on the induction of experimental autoimmune encephalomyelitis in B10.PL mice.
    Kwon SS; Kim N; Yoo TJ
    J Korean Med Sci; 2005 Dec; 20(6):1039-45. PubMed ID: 16361819
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Homeostatic control of immunity by TCR peptide-specific Tregs.
    Kumar V
    J Clin Invest; 2004 Nov; 114(9):1222-6. PubMed ID: 15520851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of a type 1 regulatory CD4 T cell response following V beta 8.2 DNA vaccination results in immune deviation and protection from experimental autoimmune encephalomyelitis.
    Kumar V; Maglione J; Thatte J; Pederson B; Sercarz E; Ward ES
    Int Immunol; 2001 Jun; 13(6):835-41. PubMed ID: 11369712
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulatory T cells specific for the same framework 3 region of the Vbeta8.2 chain are involved in the control of collagen II-induced arthritis and experimental autoimmune encephalomyelitis.
    Kumar V; Aziz F; Sercarz E; Miller A
    J Exp Med; 1997 May; 185(10):1725-33. PubMed ID: 9151697
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulator T cells: specific for antigen and/or antigen receptors?
    Rubin B; de Durana YD; Li N; Sercarz EE
    Scand J Immunol; 2003 May; 57(5):399-409. PubMed ID: 12753496
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Seven surprises in the TCR-centred regulation of immune responsiveness in an autoimmune system.
    Sercarz E; Maverakis E; van den Elzen P; Madakamutil L; Kumar V
    Novartis Found Symp; 2003; 252():165-71; discussion 171-6, 203-10. PubMed ID: 14609218
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protection against experimental autoimmune encephalomyelitis generated by a recombinant adenovirus vector expressing the V beta 8.2 TCR is disrupted by coadministration with vectors expressing either IL-4 or -10.
    Braciak TA; Pedersen B; Chin J; Hsiao C; Ward ES; Maricic I; Jahng A; Graham FL; Gauldie J; Sercarz EE; Kumar V
    J Immunol; 2003 Jan; 170(2):765-74. PubMed ID: 12517939
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunodominant framework region 3 peptide from TCR V beta 8.2 chain controls murine experimental autoimmune encephalomyelitis.
    Kumar V; Tabibiazar R; Geysen HM; Sercarz E
    J Immunol; 1995 Feb; 154(4):1941-50. PubMed ID: 7530748
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.